Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prasugrel for Prevention of Early Saphenous Vein Graft Thrombosis
NCT01560780Phase 3Completed
- Sponsor
- VA Office of Research & Development
- Start
- Feb 2013
- Primary completion
- Apr 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of prasugrel in saphenous vein graft thrombosis (SVGT), sponsored by VA Office of Research & Development. Started Feb 2013; status: completed.
02
Drugs
prasugrel
03
Conditions
saphenous vein graft thrombosis (SVGT)
Beyond the preview
Go deeper on NCT01560780.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01560780.